PMS43 - A Cost-Effectiveness Analysis of Abatacept, Tocilizumab, And Tnf-Inhibitor Compared With Rituximab As A Second-Line Therapy For Treatment of Rheumatoid Arthritis.
Saved in:
| Title: | PMS43 - A Cost-Effectiveness Analysis of Abatacept, Tocilizumab, And Tnf-Inhibitor Compared With Rituximab As A Second-Line Therapy For Treatment of Rheumatoid Arthritis. |
|---|---|
| Authors: | Huoponen, S1, Aaltonen, KJ1, Joensuu, JT1, Rutanen, J2, Relas, H3, Taimen, K4, Puolakka, K5, Sokka, T6, Nordström, D3, Blom, M1 |
| Source: | Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA538-A538. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 119164686 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PMS43 - A Cost-Effectiveness Analysis of Abatacept, Tocilizumab, And Tnf-Inhibitor Compared With Rituximab As A Second-Line Therapy For Treatment of Rheumatoid Arthritis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Huoponen%2C+S%22">Huoponen, S</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Aaltonen%2C+KJ%22">Aaltonen, KJ</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Joensuu%2C+JT%22">Joensuu, JT</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Rutanen%2C+J%22">Rutanen, J</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Relas%2C+H%22">Relas, H</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Taimen%2C+K%22">Taimen, K</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Puolakka%2C+K%22">Puolakka, K</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Sokka%2C+T%22">Sokka, T</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Nordström%2C+D%22">Nordström, D</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Blom%2C+M%22">Blom, M</searchLink><relatesTo>1</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Value+in+Health%22">Value in Health</searchLink>. Nov/Dec2016, Vol. 19 Issue 7, pA538-A538. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=119164686 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jval.2016.09.1110 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: A538 Titles: – TitleFull: PMS43 - A Cost-Effectiveness Analysis of Abatacept, Tocilizumab, And Tnf-Inhibitor Compared With Rituximab As A Second-Line Therapy For Treatment of Rheumatoid Arthritis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Huoponen, S – PersonEntity: Name: NameFull: Aaltonen, KJ – PersonEntity: Name: NameFull: Joensuu, JT – PersonEntity: Name: NameFull: Rutanen, J – PersonEntity: Name: NameFull: Relas, H – PersonEntity: Name: NameFull: Taimen, K – PersonEntity: Name: NameFull: Puolakka, K – PersonEntity: Name: NameFull: Sokka, T – PersonEntity: Name: NameFull: Nordström, D – PersonEntity: Name: NameFull: Blom, M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov/Dec2016 Type: published Y: 2016 Identifiers: – Type: issn-print Value: 10983015 Numbering: – Type: volume Value: 19 – Type: issue Value: 7 Titles: – TitleFull: Value in Health Type: main |
| ResultId | 1 |
